GM527 抗体 (Cy5)
Quick Overview for GM527 抗体 (Cy5) (ABIN1421550)
抗原
适用
宿主
克隆类型
标记
应用范围
-
-
交叉反应
- 人, 小鼠, 大鼠
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human DRIP1/C14orf28
-
亚型
- IgG
-
-
-
-
应用备注
- IF(IHC-P) 1:50-200
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- GM527 (Predicted Gene 527 (GM527))
-
别名
- DRIP1
-
背景
-
Synonyms: CN028_HUMAN, Dopamine receptor interacting protein 1, Dopamine receptor-interacting protein 1, DRIP 1, DRIP1, Uncharacterized protein C14orf28, C14orf28.
Background: 1.C14ORF28, GNB2L1, MLLT3, DRD2 and DARPP-32 are important in the pathogenesis of schizophrenia and bipolar disorder, 2. these two disorders share common disease-related mechanisms linked to dopamine signalling, 3. the expression of these genes is closely correlated, and 4. DRD2 provides the initial trigger in the pathogenesis of these disorders.
-
基因ID
- 122525
抗原
-